SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Yamagata et al. also established a therapy for Dravet syndrome in the Scn1a-haplodeficient mouse model by overactivating the intact endogenous Scn1a locus.